This website uses cookies to enhance the user experience.
STIFTELSEN INDUSTRILABORATORIET

STIFTELSEN INDUSTRILABORATORIET954 740 560

Research
Foundation
Thormøhlens gate 55 5006 BERGEN, Norge

STIFTELSEN INDUSTRILABORATORIET

Med forsøk i tankene - siden 1990 | ILab | Over 30 års erfaring
ILAB er et oppdragslaboratorium for forskning innen akvakultur. Vi holder til på Marineholmen i Bergen – verdens ledende marine klynge.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
30 years
since Feb 19, 1995
Type
Foundation
VAT registered
Yes
Number of employees
29

Financials

Total operating income 2024
53,226,432
NOK
Annual total result 2024
-1,811,345
NOK
Total equity 2024
25,454,689
NOK
Last update: Jul 26, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Deputy Chair-
Board Member-
Board Member-
Board Member-
Board Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
A
APELTUN RÅD OG REGNSKAP AS
Accountant-
Last update: May 25, 2024

Ownership

Shares owned by the STIFTELSEN INDUSTRILABORATORIET

NameShare classTotal number of sharesShare
M
MARINEHOLMEN RASLAB AS
Ordinary shares
200,353
100 %
Last update: Jun 2, 2025

Group structure

Financials

in NOK

Summary

Year2024202320222021
Total operating income
53,226,432
53,584,673
48,394,614
45,791,055
Annual Total Result
-1,811,345
963,094
-1,661,426
2,058,228
Total assets
36,724,598
38,709,239
36,404,534
40,360,573
Total liabilities
11,269,909
11,443,205
10,101,594
12,396,208
Total equity
25,454,689
27,266,034
26,302,940
27,964,365

P&L

Year2024202320222021
Total operating income
53,226,432
53,584,673
48,394,614
45,791,055
Total operating costs
50,328,773
52,438,342
50,517,079
43,259,619
Operating result
2,897,659
1,146,331
-2,122,465
2,531,436
Financial income/costs
-3,847,630
287,304
105,907
204,028
Profit before tax
-949,971
1,433,635
-2,016,558
2,735,464
Total tax & extraordinary income/cost
861,374
470,541
-355,132
677,236
Annual Total Result
-1,811,345
963,094
-1,661,426
2,058,228

Balance overview

Year2024202320222021
Total fixed assets
10,737,884
17,177,697
17,273,054
18,570,993
Total current assets
25,986,714
21,531,542
19,131,480
21,789,580
Total assets
36,724,598
38,709,239
36,404,534
40,360,573
Short term debt
11,269,909
11,443,205
10,101,594
12,396,208
Long term debt
0
0
0
0
Total liabilities
11,269,909
11,443,205
10,101,594
12,396,208
Contributed capital
750,000
750,000
750,000
750,000
Retained earnings
24,704,689
26,516,034
25,552,940
27,214,365
Total equity
25,454,689
27,266,034
26,302,940
27,964,365
Total equity and liabilities
36,724,598
38,709,239
36,404,534
40,360,573

Classification

Category
Type of organization
Foundation
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2500
Private non-profit institutions serving enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology